Biblio Discovery — Demo Discovery Service

16 results for "Lin, An-Chi"

Showing 1–16 · 0.67 seconds · RSS

  1. Journal Article Full text

    Minoxidil may suppress androgen receptor-related functions

    Hsu, Cheng-Lung; Liu, Jai-Shin; Lin, An-Chi et al.

    Oncotarget · 2014 · English · PubMed Central

    Although minoxidil has been used for more than two decades to treat androgenetic alopecia (AGA), an androgen-androgen receptor (AR) pathway-dominant disease, its precise mechanism of action remains elusive. We hypothesized that minoxidil may influence the AR or its downstream signaling. These tests…

  2. Journal Article Full text

    Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin

    Chou, Hsuan-Wen; Cheng, Kai-Pi; Lin, An-Chi et al.

    Pharmaceuticals (Basel) · 2022 · English · PubMed Central

    Glucagon-like peptide 1 receptor agonist (GLP-1 RA) is a potent antidiabetic agent with cardiorenal and weight-losing benefits in patients with type 2 diabetes (T2D). The combination of GLP-1 RA with basal insulin has been suggested in several clinical studies as a useful treatment for intensifying…

  3. Journal Article Full text

    Elevated Hedgehog-Interacting Protein Levels in Subjects with Prediabetes and Type 2 Diabetes

    Lin, An-Chi; Hung, Hao-Chang; Chen, Yun-Wen et al.

    J Clin Med · 2019 · English · PubMed Central

    …diabetes (NDD; n = 87) groups. Plasma Hhip levels were determined by an ELISA. The association between the Hhip and the presence of diabetes was examined by a multivariate linear regression analysis. Results: There were significant differences in the body mass index, systolic and diastolic blood…

  4. Journal Article Full text

    The Serum Concentrations of Hedgehog-Interacting Protein, a Novel Biomarker, Were Decreased in Overweight or Obese Subjects

    Chou, Hsuan-Wen; Hung, Hao-Chang; Lin, Ching-Han et al.

    J Clin Med · 2021 · English · PubMed Central

    Although it was known that obesity is an independent risk factor for metabolic disorders including diabetes, the factors that link these diseases were obscure. The Hedgehog-interacting protein (Hhip) is a negative regulator in tissue remodeling, and inhibits the proliferation of adipocytes, and…

  5. Journal Article Full text

    A patient-derived xenograft mouse platform from epithelioid glioblastoma provides possible druggable screening and translational study

    Lin, Chiao-Yun; Huang, Chen-Yang; Lee, Cheng-Chi et al.

    Am J Cancer Res · 2024 · English · PubMed Central

    Despite advancements in targeted therapy, glioblastoma remains a challenging condition with limited treatment options. While surgical techniques and external radiation therapy have improved, the median survival for glioblastoma stands at around 12-18 months, with a 5-year survival rate of only…

  6. Journal Article Full text

    Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening

    Hsu, Cheng-Lung; Liu, Jai-Shin; Lin, Ting-Wei et al.

    Oncotarget · 2017 · English · PubMed Central

    …AR N-C interactions. Combination of these chemicals with antiandrogen had an additive suppressive effect on AR transcriptional activity. Our collective findings may pave the way in creating new strategies for the development and design of anti-AR drugs.

  7. Journal Article Full text

    Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX model

    Kuo, Yung-Chia; Huang, Chen-Yang; Ng, Cedric Chuan Young et al.

    Am J Cancer Res · 2024 · English · PubMed Central

    …G-CSF and GM-CSF, along with their respective receptors, exerting an autocrine/paracrine effect. In our study, we successfully established four patient-derived xenograft (PDX) lines and related cell lines from urothelial cancer (UC), conducting next-generation sequencing (NGS) for genetic studies…

  8. Journal Article Full text

    Identification of a new androgen receptor (AR) co‐regulator BUD31 and related peptides to suppress wild‐type and mutated AR‐mediated prostate cancer growth via peptide screening and X‐ray structure analysis

    Hsu, Cheng-Lung; Liu, Jai-Shin; Wu, Po-Long et al.

    Mol Oncol · 2014 · English · PubMed Central

    …that these ARs bound to similar peptides, including BUD31, containing an Fxx(F/H/L/W/Y)Y motif cluster with Tyr in the +5 position. Structural analyses of the AR‐LBD‐BUD31 complex revealed formation of an extra hydrogen bond between the Tyr+5 residue of the peptide and the AR. Functional studies…

  9. Journal Article Full text

    Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma

    Hsu, Cheng-Lung; Kuo, Yung-Chia; Huang, Yenlin et al.

    Oncotarget · 2015 · English · PubMed Central

    Nasopharyngeal carcinoma (NPC) is an Epstein Barr virus (EBV)-related malignancy in which the tumor microenvironment plays a pivotal role in tumor progression. Here, we developed two patient-derived xenograft (PDX) mouse lines from engrafted NPC metastatic tumors. Positive staining for EBV-encoded…

  10. Journal Article Full text

    Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors

    Kuo, Yung-Chia; Tai, Tzong-Shyuan; Yang, Huang-Yu et al.

    Am J Cancer Res · 2024 · English · PubMed Central

    Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated cancer, and immune checkpoint inhibitors (ICIs) have shown efficacy in its treatment. The combination of chemotherapy and ICIs represents a new trend in the standard care for metastatic NPC. In this study, we aim to clarify…

  11. Journal Article Full text

    Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis

    Wang, Hung-Ming; Lin, Tung-Liang; Kuo, Yung-Chia et al.

    Oncotarget · 2016 · English · PubMed Central

    Differential overall survival of nasopharyngeal carcinoma (NPC) with different organ site metastases has been documented. Here, we attempted to determine the underlying mechanisms by assessing plasma and tumor tissue markers in relation to patient survival. Pretreatment plasma Epstein-Barr virus…

  12. Journal Article Full text

    SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma

    Huang, Chen-Yang; Lin, Chiao-Yun; Lui, Kar-Wai et al.

    Am J Cancer Res · 2026 · English · PubMed Central

    Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) - associated malignancy prevalent in South Asia, and somatostatin receptors (SSTRs), particularly SSTR2, are expressed in NPC and other solid tumors, suggesting a potential therapeutic target. We observed abundant SSTR2 expression in NPC…

  13. Journal Article Full text

    Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma

    Lin, Chiao-Yun; Huang, Chen-Yang; Lui, Kar-Wai et al.

    Transl Oncol · 2026 · English · PubMed Central

    …cell lines and patient-derived xenografts. Treatment with enzalutamide, an antiandrogen, substantially inhibited patient-derived xenografts growth and demonstrated additive antitumor effects when combined with chemotherapy in AR-positive models. Additionally, transcriptome analysis following…

  14. Journal Article Full text

    Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways

    Li, Hsin-Pai; Huang, Chen-Yang; Lui, Kar-Wai et al.

    Transl Oncol · 2023 · English · PubMed Central

    …mTOR was also associated with poor NPC prognosis. RESULTS: Everolimus, an mTOR inhibitor, suppressed tumor growth in the two PDX NPC models and had an additive antitumor effect with palbociclib, a CDK4/6 inhibitor. PDX tumors treated with various drugs or untreated were subjected to RNA sequencing…

  15. Journal Article Full text

    Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment

    Li, Hsin-Pai; Huang, Chen-Yang; Lui, Kar-Wai et al.

    Cancers (Basel) · 2021 · English · PubMed Central

    …growth and PDX tumor growth. Furthermore, combination treatment exerted an additive suppression effect on PDX tumor growth. This study provides promising evidence that EGFRi used in combination with a cell cycle blocker may be used to treat patients with NPC. ABSTRACT: Background: Nasopharyngeal…

  16. Journal Article Full text

    Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

    Hsu, Cheng-Lung; Lui, Kar-Wai; Chi, Lang-Ming et al.

    J Exp Clin Cancer Res · 2018 · English · PubMed Central

    BACKGROUND: Patient-derived xenograft (PDX) tumor model has become a new approach in identifying druggable tumor mutations, screening and evaluating personalized cancer drugs based on the mutated targets. METHODS: We established five nasopharyngeal carcinoma (NPC) PDXs in mouse model. Subsequently…